REG - Oxford Nanopore Tech - Changes to the senior leadership team

Oxford Nanopore TechnologiesAnnouncement

11/11/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241111:nRSK6493La&default-theme=true

RNS Number : 6493L  Oxford Nanopore Technologies plc  11 November 2024

 

11 November 2024

Oxford Nanopore Technologies plc

("Oxford Nanopore" or the "Company")

Oxford Nanopore announces changes to the senior leadership team

Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new
generation of nanopore-based molecular sensing technology, today announces
that Rosemary Sinclair Dokos has been appointed as Chief Product and Marketing
Officer and Dr Lakmal Jayasinghe has been appointed as Chief Scientific
Officer, effective immediately. Rosemary and Lakmal, who will report to Chief
Executive Officer Dr Gordon Sanghera, succeed Clive Brown, Chief Officer of
Technology, Innovation, and Products, who has stepped down to pursue new
projects. Clive will be available to the business on an advisory basis to
support an effective transition.

Rosemary has more than 18 years' experience in innovation, including product
management and commercial functions. She joined Oxford Nanopore in 2014 and
has been a pivotal force in driving the Company's product strategy and
execution, overseeing the development of Oxford Nanopore's platform
technologies, including the recent PromethION 2 and GridION Q-Line launches.
In her new role, Rosemary will continue leading the development of products
that include new multiomic, clinical, biopharma and industrial applications,
in addition to platform technology innovations and marketing.

Lakmal is a highly respected, world-leading nanopore and protein sensing
scientist and scientific leader, with more than 18 years' experience. He
joined Oxford Nanopore in 2007 and has been responsible for all biological
research and development projects at Oxford Nanopore. Lakmal will continue to
lead efforts to integrate new multiomic capabilities, including genomics,
transcriptomics, proteomics, and metabolomics, into the Company's platform.

Dr Gordon Sanghera, Chief Executive Officer of Oxford Nanopore, commented:

"Rosemary and Lakmal have played an integral role in the research, development
and execution of our technology vision for many years. They bring extensive
skills in innovation and product development, and the leadership of highly
skilled technical teams. These span the most cutting-edge innovation to the
deployment of mature products destined for regulated markets - critical to
creating stakeholder value. Their knowledge, perspective and vision will
advance our innovation leadership and fuel the continuation of our growth
journey.

 

"I would like to thank Clive for his profound contributions to the development
of the technology and the growth of the business over the past 16 years. He
established the Company's distinct vision of distributed, accessible
sequencing and fostered a culture of cutting-edge innovation and relentless
pursuit of pushing technological boundaries, which has shaped Oxford Nanopore
into the innovative force it is today. We continue to deliver against this
vision and will carry forward his drive to deploy big ideas and solve big
problems."

 

Clive Brown, former Chief Officer of Technology, Innovation, and Products at
Oxford Nanopore, commented:

"It has been a privilege to work alongside Gordon, Spike and the leadership
team and I am proud of all that we have achieved over the last 16 years. Given
our progress, I am now pursuing my next professional challenge. Rosemary's
focus on transformative product experiences and Lakmal's pioneering work in
multiomics put the Company in a strong position for the next phase of its
development. I would particularly like to thank the user community, who
continue to work so hard to help us improve and innovate the technology to
enable them to perform breakthrough science. I remain a dedicated shareholder
and look forward to seeing the Company continue to go from strength to
strength."

 

-ENDS-

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:         ir@nanoporetech.com (mailto:ir@nanoporetech.com)

Media:              media@nanoporetech.com
(mailto:media@nanoporetech.com)

 

Teneo (communications adviser to the Company)

Tom Murray, Olivia Peters

+44 (0) 20 7353 4200

OxfordNanoporeTechnologies@teneo.com
(mailto:OxfordNanoporeTechnologies@teneo.com)

 

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society
through enabling the analysis of anything, by anyone, anywhere. The Group has
developed a new generation of nanopore-based sensing technology that is
currently used for real-time, high-performance, accessible, and scalable
analysis of DNA and RNA. The technology is used in more than 125 countries,
to understand the biology of humans, plants, animals, bacteria, viruses and
environments as well as to understand diseases such as cancer.  Oxford
Nanopore's technology also has the potential to provide broad, high impact,
rapid insights in a number of areas including healthcare, food and
agriculture. For more information please visit: www.nanoporetech.com
(http://www.nanoporetech.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCGPGWWGUPCPPU